Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

On Slack: Rs. 1.42 Lakh Crore Refunds, Decomposing Equity Returns, Dozen Lessons on Growth, End of Net Neutrality, Payments & Investments, Self-Inflicted Losses and more….


On Slack: Rs. 1.42 Lakh Crore Refunds, Decomposing Equity Returns, Dozen Lessons on Growth, End of Net Neutrality, Payments & Investments, Self-Inflicted Losses and more….
Slack is where the daily action happens. We take pride in our diverse and always helpful member community which includes value investors, fund managers, and professional traders. Here is a brief summary of some of the interesting things discussed there in the last few days. Find all older ones here.

#Video: Payments and Investments: Deepak Shenoy, Capitalmind

#general: Things to Do After the Death of a Parent


#stocks: BCAS revokes IndiGo security centre’s suspension

‘We have conducted a fresh inspection of the training institute,’ said BCAS Director General. Business Standard

#bonds: Quantum mutual fund to start paying distributors for 1st time in 10-year history

After shunning them for years, Quantum Asset Management gets ready to welcome mutual fund distributors. Livemint

#general: Snapdeal plans to fire 30% staff in 2 months

In February 2016, Snapdeal had put over 200 employees on a Performance Improvement Program and eventually let go of the additional staff. Economic Times

#general: Can Artificial Intelligence be Used For Stock Trading?

If you’re an average retail investor who just saw a 60-minute special on artificial intelligence (AI), you probably thought to yourself “why can’t we use AI for stock trading“? Then maybe you plugged the phrase “artificial intelligence stock trading” into Google and this article popped up. We’re going to answer your question and hopefully we’ll all learn something along the way. Nanalyze

#stocks: Life Insurance Corporation Raises Stake In Infosys

The disclosure comes at a time when the company’s founders and its board have clashed over the issues of corporate governance, CEO compensation and severance pay of former CFO. NDTV Profit

#stocks: ONGC’s USD 2.4-bn Mozambique deal under Oil Min scanner

ONGC’s USD 2.475 billion purchase of Videocon Group’s 10 per cent stake in a giant Mozambique gas field has come under the Oil Ministry’s scanner following allegations that the PSU may have overpaid about USD 200 million, charges that the company vehemently denied. Bloomberg TV

#bonds: Debt funds’ self-inflicted losses

Debt fund investors made massive losses when the monetary policy was announced–and the blame lies squarely with fund companies and fund managers. Value Research Online

#macronomics: Consumers Are Going to Love the End of Net Neutrality—at First

The Trump administration looks likely to change a foundational principle of America’s tech ecosystem. WSJ

#general: CBDT issues Rs 1.42 Lakh-Crore of Refunds up to February 10, 41.5% Higher than last year

The Centralised Processing Centre (CPC) of the Income Tax Department (ITD) has already processed over 4.19 crore Income Tax Returns (ITRs) and issued over 1.62 crore refunds during the current financial year up to 10th February, 2017. The amount of refunds issued at Rs.1.42 Lakh Crore is 41.5% higher than the corresponding period last year. Taxscan

#stocks: Infosys CEO Vishal Sikka: Whistleblower’s letter a malicious, slanderous attack

In an exclusive interview to TOI immediately after meeting the media, Infosys CEO Vishal Sikka on Monday evening described a whistleblower’s letter as “a direct, reckless, malicious, slanderous and personal attack on me by diabolical minds. I will not tolerate it. It is unacceptable. If somebody attacks me personally, we will follow whatever legal recourse we have to after that.” Times of India

#stocks: Infibeam on course to acquire CC Avenue; our take

E-commerce marketplace and SAAS major Infibeam has entered into a memorandum of association with Avenues (India), which runs the payment gateway business CC Avenue; following a deal in May last year where Infibeam put in Rs 45 crore into Avenues, the company has now put in an additional Rs 150 crore, for 7.5% share in the company. Medianama

#general: National Pharmaceutical Pricing Authority slashes stent prices by up to 85%

The National Pharmaceutical Pricing Authority on Monday fixed the ceiling price of drug eluting stents (DES) and bioresorbable stents at Rs 30,000 and that of bare metal stents at Rs 7,500. The prices will be effective from notification on February 14. Times of India


A Dozen Lessons on Growth – 25IQ
Decomposing Equity Returns – Think New Found
Love it or hate it, do leave us with your reviews in the comment section below!


Like our content? Join Capitalmind Premium.

  • Equity, fixed income, macro and personal finance research
  • Model equity and fixed-income portfolios
  • Exclusive apps, tutorials, and member community
Subscribe Now Or start with a free-trial